Glucagonlike Peptide 1-Based Drugs and Pancreatitis Clarity at Last, but What About Pancreatic Cancer?

被引：16

作者：

Gier, Belinda ^{[1
]}

Butler, Peter C. ^{[1
,2
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA

来源：

JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 07期

关键词：

THERAPIES;

D O I：

10.1001/jamainternmed.2013.3374

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：539 / 541

页数：4

共 11 条

[1]

Ahmad SR, 2008, NEW ENGL J MED, V358, P1970

[2] The Safety of Incretin-Based Therapies-Review of the Scientific Evidence [J].

Drucker, Daniel J. ;

Sherman, Steven I. ;

Bergenstal, Richard M. ;

Buse, John B. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07) :2027-2031

[3] Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies [J].

Elashoff, Michael ;

Matveyenko, Aleksey V. ;

Gier, Belinda ;

Elashoff, Robert ;

Butler, Peter C. .

GASTROENTEROLOGY, 2011, 141 (01) :150-156

[4] GLP-1-Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat? [J].

Gale, Edwin A. M. .

DIABETES, 2012, 61 (05) :986-988

[5] THERAPY The second time as farce: rosiglitazone and the regulators [J].

Gale, Edwin A. M. .

NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (01) :5-6

[6] Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model [J].

Gier, Belinda ;

Matveyenko, Aleksey V. ;

Kirakossian, David ;

Dawson, David ;

Dry, Sarah M. ;

Butler, Peter C. .

DIABETES, 2012, 61 (05) :1250-1262

[7] Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland [J].

Gier, Belinda ;

Butler, Peter C. ;

Lai, Chi K. ;

Kirakossian, David ;

DeNicola, Matthew M. ;

Yeh, Michael W. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01) :121-131

[8]

Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306

[9] ELEVATED AMYLASE AND LIPASE LEVELS IN PATIENTS USING GLUCAGONLIKE PEPTIDE-1 RECEPTOR AGONISTS OR DIPEPTIDYL-PEPTIDASE-4 INHIBITORS IN THE OUTPATIENT SETTING [J].

Lando, Howard M. ;

Alattar, May ;

Dua, Anuradha P. .

ENDOCRINE PRACTICE, 2012, 18 (04) :472-477

[10] Global estimates of the prevalence of diabetes for 2010 and 2030 [J].

Shaw, J. E. ;

Sicree, R. A. ;

Zimmet, P. Z. .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) :4-14

← 1 2 →